المؤلفون: Zaratin, Paola Francesca Maria, Samadzadeh, Sara, Seferoğlu, Meral, Ricigliano, Vito A. G., Dos Santos Silva, Jonadab, TUNÇ, Abdulkadir, Montalban, Xavier

المساهمون: Institut Català de la Salut, Zaratin P Research Department, Italian Multiple Sclerosis Foundation, Genoa, Italy. Samadzadeh S Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany. Institute of Regional Health Research and Molecular Medicine, University of Southern Denmark, Odense, Denmark. Department of Neurology, The Center for Neurological Research, Næstved-Slagelse-Ringsted Hospitals, Slagelse, Denmark. Seferoğlu M Department of Neurology, Bursa Faculty of Medicine, Bursa Yüksek İhtisas Training and Research Hospital, University of Health Sciences, Bursa, Türkiye. Ricigliano V Sorbonne Université, Paris Brain Institute, ICM, CNRS, Inserm, Paris, France. Neurology Department, Pitié-Salpêtrière Hospital, APHP, Paris, France. dos Santos Silva J Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Programa de Pós Graduação Stricto Senso em Neurologia, Department of Neurology, Fluminense Federal University, Niterói, Brazil. Tunc A Department of Neurology, Sakarya University Faculty of Medicine, Sakarya, Türkiye. Montalban X Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Prognosi, Telemedicina, Pacients - Satisfacció, Avaluació de resultats (Assistència sanitària), ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires::Health Care Surveys::Patient Reported Outcome Measures, PUBLIC HEALTH::Health Care (Public Health)::Delivery of Health Care::Health Care (Public Health)::Health Care (Public Health)::Telemedicine, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios::encuestas sobre atención a la salud::medidas de resultados percibidos por los pacientes, SALUD PÚBLICA::atención a la salud (salud pública)::prestación sanitaria::atención a la salud (salud pública)::atención a la salud (salud pública)::telemedicina, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad

وصف الملف: application/pdf

Relation: Frontiers in Neurology;15; https://doi.org/10.3389/fneur.2024.1407257; Zaratin P, Samadzadeh S, Seferoğlu M, Ricigliano V, dos Santos Silva J, Tunc A, et al. The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care – updates at the 2023 plenary event. Front Neurol. 2024 Jun 20;15:1407257.; https://hdl.handle.net/11351/11693

الاتاحة: https://hdl.handle.net/11351/11693
https://doi.org/10.3389/fneur.2024.1407257

المؤلفون: Lunemann, Jan, Hegen, Harald, Rejdak, Konrad, Carbonell Mirabent, Pere, Gutiérrez Ruiz, Lucía, Villar, Luisa M, Sao Aviles, Augusto, Sastre Garriga, Jaume, Mongay-Ochoa, Neus, Fissolo, Nicolás Miguel, Villacieros-Álvarez, Javier, Montalban, Xavier, Comabella Lopez, Manuel

المساهمون: Institut Català de la Salut, Lunemann JD Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Germany. Hegen H Department of Neurology, Medical University of Innsbruck, Austria. Villar LM Departments of Neurology and Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramon y Cajal de Investigación Sanitaria. Rejdak K Department of Neurology, Medical University of Lublin, Poland. Sao-Aviles A, Carbonell-Mirabent P, Sastre-Garriga J, Mongay-Ochoa N, Gutierrez L, Villacieros-Álvarez J Servei de Neurologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Fissolo N, Montalban X, Comabella M Servei de Neurologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) - ISCIII, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Prognosi, Persones amb discapacitat, Proteïnes de la sang, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis::Multiple Sclerosis, Chronic Progressive, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Complement System Proteins, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Disability Evaluation, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple::esclerosis múltiple crónica progresiva, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::proteínas del sistema del complemento, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::valoración de discapacidades

وصف الملف: application/pdf

Relation: Neurology, Neuroimmunology and Neuroinflammation;11(4); https://doi.org/10.1212/NXI.0000000000200270; Lunemann JD, Hegen H, Villar LM, Rejdak K, Sao-Aviles A, Carbonell-Mirabent P, et al. Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation. 2024 Jul;11(4):e200270.; https://hdl.handle.net/11351/11695

الاتاحة: https://hdl.handle.net/11351/11695
https://doi.org/10.1212/NXI.0000000000200270

المؤلفون: Ciccarelli, Olga, Calabrese, Massimiliano, De Stefano, Nicola, Eshaghi, Arman, Filippi, Massimo, Barkhof, Frederik, Rovira, Alex, Sastre Garriga, Jaume, TUR, CARMEN

المساهمون: Institut Català de la Salut, Ciccarelli O Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, National Institute for Health and Care Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, United Kingdom. Barkhof F Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, Centre for Medical Image Computing, University College London, United Kingdom, Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands. Calabrese M Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy. De Stefano N Department of Medicine, Surgery and Neuroscience, University of Siena, Italy. Eshaghi A Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, United Kingdom. Filippi M Neuroimaging Research Unit, Division of Neuroscience, and Neurology Unit, Neurorehabilitation Unit, Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy. Rovira À Secció de Neurorradiologia, Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Sastre-Garriga J, Tur C Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Imatgeria per ressonància magnètica, Esclerosi múltiple - Prognosi, Persones amb discapacitat, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Tomography::Magnetic Resonance Imaging, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Disability Evaluation, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::tomografía::imagen por resonancia magnética, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::valoración de discapacidades

وصف الملف: application/pdf

Relation: Neurology;103(1); https://doi.org/10.1212/WNL.0000000000209444; info:eu-repo/grantAgreement/ES/PE2017-2020/PI21%2F01860; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI22%2F01589; info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00950; Ciccarelli O, Barkhof F, Calabrese M, De Stefano N, Eshaghi A, Filippi M, et al. Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis. Neurology. 2024 Jul 9;103(1):e209444.; https://hdl.handle.net/11351/11625

الاتاحة: https://hdl.handle.net/11351/11625
https://doi.org/10.1212/WNL.0000000000209444

المؤلفون: Fleischer, Vinzenz, Gonzalez Escamilla, Gabriel, Pareto, Deborah, Sowa, Piotr, Rovira, Alex, Sastre Garriga, Jaume

المساهمون: Institut Català de la Salut, Fleischer V, Gonzalez-Escamilla G Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Pareto D, Rovira A Secció de Neurorradiologia, Radiodiagnòstic (IDI), Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Sastre-Garriga J Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Sowa P Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Imatgeria per ressonància magnètica, Esclerosi múltiple - Prognosi, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Tomography::Magnetic Resonance Imaging, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression, ANATOMY::Nervous System::Central Nervous System::Brain::Gray Matter, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::tomografía::imagen por resonancia magnética, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad, ANATOMÍA::sistema nervioso::sistema nervioso central::encéfalo::sustancia gris

وصف الملف: application/pdf

Relation: Brain;147(1); https://doi.org/10.1093/brain/awad288; info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F00823; Fleischer V, Gonzalez-Escamilla G, Pareto D, Rovira A, Sastre-Garriga J, Sowa P, et al. Prognostic value of single-subject grey matter networks in early multiple sclerosis. Brain. 2024 Jan;147(1):135–46.; https://hdl.handle.net/11351/10930; 001114878800001

الاتاحة: https://hdl.handle.net/11351/10930
https://doi.org/10.1093/brain/awad288

المؤلفون: Coll, Llucia, Carbonell Mirabent, Pere, Castillo Justribo, Joaquin, Galan, Ingrid, Nos, Carlos, Auger, Cristina, Alberich, Manel, Pareto, Deborah, Cobo-Calvo, Alvaro, Arrambide, Georgina, Vidal-Jordana, Angela, Comabella Lopez, Manuel, Rodriguez Acevedo, Breogan, Zabalza, Ana, midaglia, luciana, Rio, Jordi, Sastre Garriga, Jaume, Montalban, Xavier, Rovira, Alex, Tintore, Mar, TUR, CARMEN

المساهمون: Institut Català de la Salut, Coll L, Carbonell-Mirabent P, Cobo-Calvo Á, Arrambide G, Vidal-Jordana Á, Comabella M, Castilló J, Rodríguez-Acevedo B, Zabalza A, Galán I, Midaglia L, Nos C, Río J, Sastre-Garriga J, Montalban X, Tintoré M, Tur C Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Pareto D, Auger C, Alberich M, Rovira À Secció de Neuroradiologia, Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Aprenentatge automàtic, Esclerosi múltiple - Prognosi, Imatgeria per ressonància magnètica, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, Other subheadings::Other subheadings::/diagnosis, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Tomography::Magnetic Resonance Imaging, PHENOMENA AND PROCESSES::Mathematical Concepts::Mathematical Concepts::Neural Networks (Computer)::Deep Learning, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, Otros calificadores::Otros calificadores::/diagnóstico, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::tomografía::imagen por resonancia magnética, FENÓMENOS Y PROCESOS::conceptos matemáticos::conceptos matemáticos::redes neuronales (ordenador)::aprendizaje profundo

وصف الملف: application/pdf

Relation: Journal of Magnetic Resonance Imaging;60(1); https://doi.org/10.1002/jmri.29046; Coll L, Pareto D, Carbonell-Mirabent P, Cobo-Calvo Á, Arrambide G, Vidal-Jordana Á, et al. Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI. J Magn Reson Imaging. 2024 Jul;60(1):258–67.; https://hdl.handle.net/11351/11572; 001079314200001

الاتاحة: https://hdl.handle.net/11351/11572
https://doi.org/10.1002/jmri.29046

المؤلفون: Sahi, Nitin, Haider, Lukas, Chung, Karen, Kanber, Baris, Samson, Rebecca, Tur Gomez, Carmen, Prados Carrasco, Ferran

المساهمون: Institut Català de la Salut, Sahi N, Chung K, Samson R NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London Queen Square Institute of Neurology, London, UK. Haider L NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London Queen Square Institute of Neurology, London, UK. Department of Biomedical Imaging and Image Guided Therapy, Medical University Vienna, Vienna, Austria. Prados Carrasco F NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London Queen Square Institute of Neurology, London, UK. Centre for Medical Image Computing (CMIC), Department of Medical Physics and Biomedical Engineering, University College London, London, UK. Universitat Oberta de Catalunya, Barcelona, Spain. Kanber B NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London Queen Square Institute of Neurology, London, UK. Centre for Medical Image Computing (CMIC), Department of Medical Physics and Biomedical Engineering, University College London, London, UK. Department of Clinical and Experimental Epilepsy, University College London, London, UK. Tur C NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London Queen Square Institute of Neurology, London, UK. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Prognosi, Esclerosi múltiple - Aspectes genètics, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, Other subheadings::Other subheadings::Other subheadings::/genetics, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, Otros calificadores::Otros calificadores::Otros calificadores::/genética, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico

وصف الملف: application/pdf

Relation: Brain Communications;5(5); https://doi.org/10.1093/braincomms/fcad255; Sahi N, Haider L, Chung K, Prados Carrasco F, Kanber B, Samson R, et al. Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome. Brain Commun. 2023;5(5):fcad255.; https://hdl.handle.net/11351/10566; 001081433800001

الاتاحة: https://hdl.handle.net/11351/10566
https://doi.org/10.1093/braincomms/fcad255

المؤلفون: Rotstein, Dalia, Solomon, Jacqueline, Sormani, Maria Pia, Montalban Gairín, Xavier, Ye, Xiang Y., Dababneh, Dina

المساهمون: Institut Català de la Salut, Rotstein D Department of Medicine, University of Toronto, Ontario, Canada, St. Michael’s Hospital, Toronto, Ontario, Canada. Solomon JM Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Sormani MP Department of Health Sciences, Section of Biostatistics, University of Genova, Italy, IRCCS Ospedale Policlinico San Martino, Genova, Italy. Montalban X Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya, Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Ye XY Department of Pediatrics, Mount Sinai Hospital, Toronto, Canada. Dababneh D Columbia University Irving Medical Center, Department of Neurology, New York City, New York Presbyterian Hospital (NYP), New York City, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Tractament, Esclerosi múltiple - Prognosi, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad

وصف الملف: application/pdf

Relation: Neurology, Neuroimmunology and Neuroinflammation;9(6); https://doi.org/10.1212/NXI.0000000000200032; Rotstein D, Solomon JM, Sormani MP, Montalban X, Ye XY, Dababneh D, et al. Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis. Neurol Neuroimmunol Neuroinflamm. 2022 Nov;9(6):e200032.; https://hdl.handle.net/11351/8502; 000874687300005

الاتاحة: https://hdl.handle.net/11351/8502
https://doi.org/10.1212/NXI.0000000000200032

المؤلفون: Meca-Lallana, Jose Eustasio, Casanova, Bonaventura, Rodríguez-Antigüedad, Alfredo, Eichau-Madueño, Sara, Izquierdo, Guillermo, Durán, Carmen, Rio Izquierdo, Jordi

المساهمون: Institut Català de la Salut, Meca-Lallana JE CSUR Multiple Sclerosis and Clinical Neuroimmunology Unit, Neurology Department, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain. Casanova B Department of Neurology, Hospital Universitario y Politécnico La Fe, Valencia, Spain. Rodríguez-Antigüedad A Department of Neurology, Hospital Universitario Cruces, Barakaldo, Spain. Eichau S Department of Neurology, Hospital Universitario Virgen Macarena, Sevilla, Spain. Izquierdo G Fundación DINAC, Sevilla, Spain. Durán C Department of Neurology, Hospital Universitario de Badajoz, Badajoz, Spain. Río J Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Diagnòstic, Presa de decisions, Esclerosi múltiple - Prognosi, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, Other subheadings::Other subheadings::/diagnosis, PSYCHIATRY AND PSYCHOLOGY::Psychological Phenomena::Mental Processes::Thinking::Decision Making::Consensus, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, Otros calificadores::Otros calificadores::/diagnóstico, PSIQUIATRÍA Y PSICOLOGÍA::fenómenos psicológicos::procesos mentales::pensamiento::toma de decisión::consenso

وصف الملف: application/pdf

Relation: Frontiers in Neurology;13; https://doi.org/10.3389/fneur.2022.931014; Meca-Lallana JE, Casanova B, Rodríguez-Antigüedad A, Eichau S, Izquierdo G, Durán C, et al. Consensus on early detection of disease progression in patients with multiple sclerosis. Front Neurol. 2022 Jul 28;13:931014.; https://hdl.handle.net/11351/8381; 000844632600001

الاتاحة: https://hdl.handle.net/11351/8381
https://doi.org/10.3389/fneur.2022.931014

المؤلفون: Saiz, Albert, Martínez-Yélamos, Sergio, Pinteac, Rucsanda, Vidal Jordana, Angela, Montalban Gairín, Xavier, Sastre Garriga, Jaume, Comabella Lopez, Manuel, Villar, Luisa M, Fissolo, Nicolás Miguel, Borràs, Eva

المساهمون: Institut Català de la Salut, Comabella M, Sastre-Garriga J, Pinteac R, Fissolo N, Vidal-Jordana A, Montalban X Unitat de Neuroimmunologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Borras E Proteomics Unit, Universitat Pompeu Fabra, Barcelona. Villar LM Departments of Neurology and Immunology, Hospital Universitario Ramon y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid. Saiz A Service of Neurology, Hospital Clinic and Institut d’Investigacions Biomèdiques August Pi Sunyer, University of Barcelona. Martínez-Yélamos S Department of Neurology, Bellvitge University Hospital, Barcelona, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Glicosidases, Esclerosi múltiple - Prognosi, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis::Multiple Sclerosis, Chronic Progressive, CHEMICALS AND DRUGS::Enzymes and Coenzymes::Enzymes::Hydrolases::Glycoside Hydrolases::Chitinases, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple::esclerosis múltiple crónica progresiva, COMPUESTOS QUÍMICOS Y DROGAS::enzimas y coenzimas::enzimas::hidrolasas::glicósido hidrolasas::quitinasas, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad

وصف الملف: application/pdf

Relation: Neurology - Neuroimmunology & Neuroinflammation;8(6); https://doi.org/10.1212/NXI.0000000000001082; Comabella M, Sastre-Garriga J, Borras E, Villar LM, Saiz A, Martínez-Yélamos S, et al. CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021 Nov;8(6):e1082.; https://hdl.handle.net/11351/7442; 000712132000035

الاتاحة: https://hdl.handle.net/11351/7442
https://doi.org/10.1212/NXI.0000000000001082

المؤلفون: Bittner, Stefan, Kubala Havrdova, Eva, Tintore Subirana, Mar, Zipp, Frauke, Oh, Jiwon

المساهمون: Institut Català de la Salut, Bittner S, Zipp F Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz 55131, Germany. Oh J Division of Neurology, Department of Medicine, St Michael’s Hospital, University of Toronto, Toronto, Ontario M5S 3H2, Canada. Kubala Havrdová E Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague 116 36, Czech Republic. Tintoré M Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Imatgeria per ressonància magnètica, Filaments citoplasmàtics, Esclerosi múltiple - Prognosi, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Amino Acids, and Proteins::Proteins::Nerve Tissue Proteins::Neurofilament Proteins, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, Other subheadings::Other subheadings::Other subheadings::/diagnostic imaging, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::aminoácidos, péptidos y proteínas::proteínas::proteínas del tejido nervioso::proteínas de neurofilamentos, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, Otros calificadores::Otros calificadores::Otros calificadores::/diagnóstico por imagen, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico

وصف الملف: application/pdf

Relation: Brain;144(10); https://doi.org/10.1093/brain/awab241; Bittner S, Oh J, Kubala Havrdová E, Tintoré M, Zipp F. The potential of serum neurofilament as biomarker for multiple sclerosis. Brain. 2021 Oct;144(10):2954–63.; https://hdl.handle.net/11351/7631; 000733375400012

الاتاحة: https://hdl.handle.net/11351/7631
https://doi.org/10.1093/brain/awab241

المؤلفون: Boonsuth, Ratthaporn, Samson, Rebecca S., Tur Gomez, Carmen, Battiston, Marco, Schneider, Torben, Grussu, Francesco

المساهمون: Institut Català de la Salut, Boonsuth R, Samson RS, Battiston M Nuclear Magnetic Resonance Research Unit, Queen Square MS Centre, Department of Neuroinflammation, University College London Queen Square Institute of Neurology, University College London, London, United Kingdom. Tur C Nuclear Magnetic Resonance Research Unit, Queen Square MS Centre, Department of Neuroinflammation, University College London Queen Square Institute of Neurology, University College London, London, United Kingdom. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. Grussu F Nuclear Magnetic Resonance Research Unit, Queen Square MS Centre, Department of Neuroinflammation, University College London Queen Square Institute of Neurology, University College London, London, United Kingdom. Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. Centre for Medical Image Computing, Department of Computer Science, University College London, London, United Kingdom. Schneider T Philips Healthcare, Guildford, Surrey, United Kingdom, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Complicacions, Imatgeria per ressonància magnètica, Esclerosi múltiple - Prognosi, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis::Multiple Sclerosis, Relapsing-Remitting, Other subheadings::Other subheadings::Other subheadings::/complications, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Tomography::Magnetic Resonance Imaging, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple::esclerosis múltiple recurrente-remitente, Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::tomografía::imagen por resonancia magnética, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad

وصف الملف: application/pdf

Relation: Frontiers in Neurology;12; https://doi.org/10.3389/fneur.2021.763143; info:eu-repo/grantAgreement/EC/H2020/634541; Boonsuth R, Samson RS, Tur C, Battiston M, Grussu F, Schneider T, et al. Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio. Front Neurol. 2021 Nov;12:763143.; https://hdl.handle.net/11351/7548; 000729107800001

الاتاحة: https://hdl.handle.net/11351/7548
https://doi.org/10.3389/fneur.2021.763143

المؤلفون: Dalia Rotstein, Jacqueline M. Solomon, Maria Pia Sormani, Xavier Montalban, Xiang Y. Ye, Dina Dababneh, Alexandra Muccilli, Georges Saab, Prakesh Shah

المساهمون: Institut Català de la Salut, [Rotstein D] Department of Medicine, University of Toronto, Ontario, Canada, St. Michael’s Hospital, Toronto, Ontario, Canada. [Solomon JM] Department of Medicine, McMaster University, Hamilton, Ontario, Canada. [Sormani MP] Department of Health Sciences, Section of Biostatistics, University of Genova, Italy, IRCCS Ospedale Policlinico San Martino, Genova, Italy. [Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya, Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Ye XY] Department of Pediatrics, Mount Sinai Hospital, Toronto, Canada. [Dababneh D] Columbia University Irving Medical Center, Department of Neurology, New York City, New York Presbyterian Hospital (NYP), New York City, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Multiple Sclerosis, Fingolimod Hydrochloride, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis [DISEASES], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Interferon-beta, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Esclerosi múltiple - Prognosi, afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad [ENFERMEDADES], Multiple Sclerosis, Relapsing-Remitting, Neurology, enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES], Disease Progression, Humans, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression [DISEASES], Neurology (clinical), Esclerosi múltiple - Tractament

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f4dbc888a8e3982e13ea6abebfc418
https://pubmed.ncbi.nlm.nih.gov/36224046

المؤلفون: Sara Llufriu, Albert Saiz, Luisa M. Villar, Eva Borràs, Antonio J. Sánchez López, Manuel Comabella, Sergio Martínez-Yélamos, Eduard Sabidó, J.A. García-Merino, Rucsanda Pinteac, Lucienne Costa-Frossard, Yolanda Blanco, Xavier Montalban, Jaume Sastre-Garriga, Angela Vidal-Jordana, Nicolás Fissolo

المساهمون: Institut Català de la Salut, [Comabella M, Sastre-Garriga J, Pinteac R, Fissolo N, Vidal-Jordana A, Montalban X] Unitat de Neuroimmunologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Borras E] Proteomics Unit, Universitat Pompeu Fabra, Barcelona. [Villar LM] Departments of Neurology and Immunology, Hospital Universitario Ramon y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid. [Saiz A] Service of Neurology, Hospital Clinic and Institut d’Investigacions Biomèdiques August Pi Sunyer, University of Barcelona. [Martínez-Yélamos S] Department of Neurology, Bellvitge University Hospital, Barcelona, Vall d'Hebron Barcelona Hospital Campus

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
Scientia
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Enzymes and Coenzymes::Enzymes::Hydrolases::Glycoside Hydrolases::Chitinases [CHEMICALS AND DRUGS], enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple::esclerosis múltiple crónica progresiva [ENFERMEDADES], Esclerosi múltiple, Article, Multiple sclerosis, Glicosidases, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis::Multiple Sclerosis, Chronic Progressive [DISEASES], Internal medicine, Cathepsin L1, medicine, Humans, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression [DISEASES], enzimas y coenzimas::enzimas::hidrolasas::glicósido hidrolasas::quitinasas [COMPUESTOS QUÍMICOS Y DROGAS], Shotgun proteomics, CSF albumin, biology, business.industry, Chitinases, Biochemical markers, Patient Acuity, Area under the curve, Middle Aged, Multiple Sclerosis, Chronic Progressive, Prognosis, Esclerosi múltiple - Prognosi, afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad [ENFERMEDADES], Clinical trial, Neurology, Estudi de casos, Chitinase, Cohort, Marcadors bioquímics, Disease Progression, biology.protein, Biomarker (medicine), Female, Neurology (clinical), Case studies, business, Biomarkers, Follow-Up Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99a8c1143873c1eb36072ddb0b4dda07
http://hdl.handle.net/2445/181334

المؤلفون: Domínguez Núñez, Antía

المساهمون: Universitat de Girona. Facultat de Medicina, Robles Cedeño, René

المصدر: Medicina (TFG)
DUGiDocs – Universitat de Girona
instname

مصطلحات موضوعية: CD antigens, Antígens CD, Marcadors bioquímics, Biochemical markers, Multiple slcerosis -- Prognosis, Esclerosi múltiple -- Prognosi

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::333b8c69d6fca9c0564a1da894e6f0cf
http://hdl.handle.net/10256/14165